chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Pain in extremity, Pyrexia, Vaccination site erythema
Clinical narrative: back pain; itchy; red and blotchy; low grade temperature; fatigue; arms were sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BACK PAIN (back pain), PAIN IN EXTREMITY (arms were sore), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red and blotchy) and PYREXIA (low grade temperature) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (arms were sore) and FATIGUE (fatigue). On 14-Feb-2021, the patient experienced PYREXIA (low grade temperature). On 20-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red and blotchy). On 21-Feb-2021, the patient experienced BACK PAIN (back pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 14-Feb-2021, PAIN IN EXTREMITY (arms were sore) had resolved. On 15-Feb-2021, FATIGUE (fatigue) had resolved. On 17-Feb-2021, PYREXIA (low grade temperature) had not resolved. At the time of the report, BACK PAIN (back pain) had not resolved, VACCINATION SITE PRURITUS (itchy) had resolved and VACCINATION SITE ERYTHEMA (red and blotchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-023217.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: back pain; itchy; red and blotchy; low grade temperature; fatigue; arms were sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BACK PAIN (back pain), PAIN IN EXTREMITY (arms were sore), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red and blotchy) and PYREXIA (low grade temperature) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (arms were sore) and FATIGUE (fatigue). On 14-Feb-2021, the patient experienced PYREXIA (low grade temperature). On 20-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red and blotchy). On 21-Feb-2021, the patient experienced BACK PAIN (back pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 14-Feb-2021, PAIN IN EXTREMITY (arms were sore) had resolved. On 15-Feb-2021, FATIGUE (fatigue) had resolved. On 17-Feb-2021, PYREXIA (low grade temperature) had not resolved. At the time of the report, BACK PAIN (back pain) had not resolved, VACCINATION SITE PRURITUS (itchy) had resolved and VACCINATION SITE ERYTHEMA (red and blotchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-023217.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Vaccination site pain
Clinical narrative: Loose stools; Vaccination site Pain; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Loose stools) and VACCINATION SITE PAIN (Vaccination site Pain) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Parkinson's disease since an unknown date. Concomitant products included SENNOSIDE A for Parkinson's disease.    On 06-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site Pain). On 11-Feb-2021, the patient experienced DIARRHOEA (Loose stools). At the time of the report, DIARRHOEA (Loose stools) and VACCINATION SITE PAIN (Vaccination site Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot
Clinical narrative: Body is feeling hot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Body is feeling hot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Body is feeling hot). At the time of the report, FEELING HOT (Body is feeling hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: 3 swollwn lymph nodes on her neck; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (3 swollwn lymph nodes on her neck) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Thyroid cancer.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced LYMPHADENOPATHY (3 swollwn lymph nodes on her neck). At the time of the report, LYMPHADENOPATHY (3 swollwn lymph nodes on her neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: injection site warmth; injection site itching; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (injection site warmth), INJECTION SITE PRURITUS (injection site itching) and INJECTION SITE ERYTHEMA (injection site redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021 at 3:46 AM, the patient experienced INJECTION SITE WARMTH (injection site warmth), INJECTION SITE PRURITUS (injection site itching) and INJECTION SITE ERYTHEMA (injection site redness). At the time of the report, INJECTION SITE WARMTH (injection site warmth), INJECTION SITE PRURITUS (injection site itching) and INJECTION SITE ERYTHEMA (injection site redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: severe headache; feel tired and lazy; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headache) and FATIGUE (feel tired and lazy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (severe headache) and FATIGUE (feel tired and lazy). At the time of the report, HEADACHE (severe headache) and FATIGUE (feel tired and lazy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-022357 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-022357:same reporter, diff patient (male)
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Lethargy, Myalgia
Clinical narrative: mild headache; felt lethargic; tired; felt sore at the injection site; body aches; This spontaneous case was reported by a health care professional and describes the occurrence of HEADACHE (mild headache), LETHARGY (felt lethargic), FATIGUE (tired), INJECTION SITE PAIN (felt sore at the injection site) and MYALGIA (body aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced HEADACHE (mild headache), LETHARGY (felt lethargic), FATIGUE (tired), INJECTION SITE PAIN (felt sore at the injection site) and MYALGIA (body aches). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 17-Jan-2021, HEADACHE (mild headache), LETHARGY (felt lethargic), FATIGUE (tired), INJECTION SITE PAIN (felt sore at the injection site) and MYALGIA (body aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-022368 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: Warmness; Slight Headache; Circular Swelling of four inches in size at the injection site; Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warmness), HEADACHE (Slight Headache), INJECTION SITE SWELLING (Circular Swelling of four inches in size at the injection site) and PRURITUS (Itchiness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE WARMTH (Warmness), HEADACHE (Slight Headache), INJECTION SITE SWELLING (Circular Swelling of four inches in size at the injection site) and PRURITUS (Itchiness). At the time of the report, INJECTION SITE WARMTH (Warmness), HEADACHE (Slight Headache), INJECTION SITE SWELLING (Circular Swelling of four inches in size at the injection site) and PRURITUS (Itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment provided was cold compression.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Injection site discolouration, Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Blueish purple injection site; Red injection site; Hot injection site; Chest tightness; Could not talk very well; Itching injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Hot injection site), INJECTION SITE DISCOLOURATION (Blueish purple injection site), CHEST DISCOMFORT (Chest tightness), SPEECH SOUND DISORDER (Could not talk very well) and INJECTION SITE PRURITUS (Itching injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Red injection site). On 16-Feb-2021, the patient experienced INJECTION SITE DISCOLOURATION (Blueish purple injection site). On an unknown date, the patient experienced INJECTION SITE WARMTH (Hot injection site), CHEST DISCOMFORT (Chest tightness), SPEECH SOUND DISORDER (Could not talk very well) and INJECTION SITE PRURITUS (Itching injection site). At the time of the report, INJECTION SITE WARMTH (Hot injection site), INJECTION SITE DISCOLOURATION (Blueish purple injection site), CHEST DISCOMFORT (Chest tightness), SPEECH SOUND DISORDER (Could not talk very well), INJECTION SITE PRURITUS (Itching injection site) and INJECTION SITE ERYTHEMA (Red injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Speech sound disorder
Clinical narrative: Blueish purple injection site; Red injection site; Hot injection site; Chest tightness; Could not talk very well; Itching injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Hot injection site), INJECTION SITE DISCOLOURATION (Blueish purple injection site), CHEST DISCOMFORT (Chest tightness), SPEECH SOUND DISORDER (Could not talk very well) and INJECTION SITE PRURITUS (Itching injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Red injection site). On 16-Feb-2021, the patient experienced INJECTION SITE DISCOLOURATION (Blueish purple injection site). On an unknown date, the patient experienced INJECTION SITE WARMTH (Hot injection site), CHEST DISCOMFORT (Chest tightness), SPEECH SOUND DISORDER (Could not talk very well) and INJECTION SITE PRURITUS (Itching injection site). At the time of the report, INJECTION SITE WARMTH (Hot injection site), INJECTION SITE DISCOLOURATION (Blueish purple injection site), CHEST DISCOMFORT (Chest tightness), SPEECH SOUND DISORDER (Could not talk very well), INJECTION SITE PRURITUS (Itching injection site) and INJECTION SITE ERYTHEMA (Red injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Rhinorrhoea, Thirst
Clinical narrative: extreme thirst; runny nose; sore throat; head ache; This spontaneous case was reported by a consumer and describes the occurrence of THIRST (extreme thirst), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat) and HEADACHE (head ache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THIRST (extreme thirst), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat) and HEADACHE (head ache). At the time of the report, THIRST (extreme thirst), RHINORRHOEA (runny nose), OROPHARYNGEAL PAIN (sore throat) and HEADACHE (head ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain in extremity, Tinnitus, Vaccination site erythema
Clinical narrative: painful left palm hand; swollen at the injection site; redness at the injection site; nausea; chills; slight, mild ring in her ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (slight, mild ring in her ears), PAIN IN EXTREMITY (painful left palm hand), VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and NAUSEA (nausea) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included Blood pressure medication for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced TINNITUS (slight, mild ring in her ears). On an unknown date, the patient experienced PAIN IN EXTREMITY (painful left palm hand), VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), NAUSEA (nausea) and CHILLS (chills). On 21-Jan-2021, TINNITUS (slight, mild ring in her ears) was resolving. At the time of the report, PAIN IN EXTREMITY (painful left palm hand), VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), NAUSEA (nausea) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Ice on the painful palm of her left hand.   Reporter did not allow further contact
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: painful left palm hand; swollen at the injection site; redness at the injection site; nausea; chills; slight, mild ring in her ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (slight, mild ring in her ears), PAIN IN EXTREMITY (painful left palm hand), VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and NAUSEA (nausea) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included Blood pressure medication for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced TINNITUS (slight, mild ring in her ears). On an unknown date, the patient experienced PAIN IN EXTREMITY (painful left palm hand), VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), NAUSEA (nausea) and CHILLS (chills). On 21-Jan-2021, TINNITUS (slight, mild ring in her ears) was resolving. At the time of the report, PAIN IN EXTREMITY (painful left palm hand), VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), NAUSEA (nausea) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Ice on the painful palm of her left hand.   Reporter did not allow further contact
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 007M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Actos 100 mg, Metformin 500 mg, Losartan potassium 100 mg, Amlodipine 10 mg, Atenolol 25 mg, Isosorbide Mononitrate 30 mg, Atorvastatin (Lipitor) and Klor-Con 10 for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Vaccination site pain, Vaccination site swelling
Clinical narrative: Can't sleep on side with injection; experiencing pain in her arm after received the vaccine; swelling in her arm after she received the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Can't sleep on side with injection), VACCINATION SITE PAIN (experiencing pain in her arm after received the vaccine) and VACCINATION SITE SWELLING (swelling in her arm after she received the vaccine) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and GABAPENTIN for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced INSOMNIA (Can't sleep on side with injection), VACCINATION SITE PAIN (experiencing pain in her arm after received the vaccine) and VACCINATION SITE SWELLING (swelling in her arm after she received the vaccine). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INSOMNIA (Can't sleep on side with injection), VACCINATION SITE PAIN (experiencing pain in her arm after received the vaccine) and VACCINATION SITE SWELLING (swelling in her arm after she received the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: I'm not feeling too good; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I'm not feeling too good) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I'm not feeling too good). At the time of the report, ILLNESS (I'm not feeling too good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Feeling cold, Irritability, Myalgia
Clinical narrative: irritation; feels cold; sore; larger redness; fatigue; Her arm got redder at the injection site; she has muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of IRRITABILITY (irritation), FEELING COLD (feels cold), PAIN (sore), ERYTHEMA (larger redness) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced IRRITABILITY (irritation), FEELING COLD (feels cold), PAIN (sore), ERYTHEMA (larger redness), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (Her arm got redder at the injection site) and MYALGIA (she has muscle pain). At the time of the report, IRRITABILITY (irritation), FEELING COLD (feels cold), PAIN (sore), ERYTHEMA (larger redness), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (Her arm got redder at the injection site) and MYALGIA (she has muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. Treatment medication included acetaminophen.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site erythema
Clinical narrative: irritation; feels cold; sore; larger redness; fatigue; Her arm got redder at the injection site; she has muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of IRRITABILITY (irritation), FEELING COLD (feels cold), PAIN (sore), ERYTHEMA (larger redness) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced IRRITABILITY (irritation), FEELING COLD (feels cold), PAIN (sore), ERYTHEMA (larger redness), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (Her arm got redder at the injection site) and MYALGIA (she has muscle pain). At the time of the report, IRRITABILITY (irritation), FEELING COLD (feels cold), PAIN (sore), ERYTHEMA (larger redness), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (Her arm got redder at the injection site) and MYALGIA (she has muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. Treatment medication included acetaminophen.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: leaky needle with what he thinks is the full dose; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of INCORRECT DOSE ADMINISTERED (leaky needle with what he thinks is the full dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (leaky needle with what he thinks is the full dose). At the time of the report, INCORRECT DOSE ADMINISTERED (leaky needle with what he thinks is the full dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Injection site pain, Myalgia
Clinical narrative: pain at the injection sire; CHILLS; body aches for a day; A spontaneous report  was received from a Healthcare Professional concerning a male patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain at the injection sire, chills, body aches for a day.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 21 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: UNKNOWN) for prophylaxis of COVID-19 infection.  On 21 Jan 2021, the patient experienced the events pain at the injection sire. chills, body aches for a day.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  On 22 Jan 2021 the outcome of events pain at the injection sire was resolved.On 22 Jan 2021 the outcome of events chills was resolved.On 22 Jan 2021 the outcome of events body aches for a day was resolved. .; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fall, Fatigue, Hypoaesthesia
Clinical narrative: felt their legs were numb; weakness; fell to floor because of numbness; had fever and chills; extreme fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (felt their legs were numb), ASTHENIA (weakness), FALL (fell to floor because of numbness), PYREXIA (had fever and chills) and FATIGUE (extreme fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Dec-2020.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (felt their legs were numb), ASTHENIA (weakness), FALL (fell to floor because of numbness), PYREXIA (had fever and chills), FATIGUE (extreme fatigue) and CHILLS (chills). At the time of the report, HYPOAESTHESIA (felt their legs were numb), ASTHENIA (weakness), FALL (fell to floor because of numbness), PYREXIA (had fever and chills), FATIGUE (extreme fatigue) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2020, SARS-CoV-2 test: (Positive) tested positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: felt their legs were numb; weakness; fell to floor because of numbness; had fever and chills; extreme fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (felt their legs were numb), ASTHENIA (weakness), FALL (fell to floor because of numbness), PYREXIA (had fever and chills) and FATIGUE (extreme fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Dec-2020.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (felt their legs were numb), ASTHENIA (weakness), FALL (fell to floor because of numbness), PYREXIA (had fever and chills), FATIGUE (extreme fatigue) and CHILLS (chills). At the time of the report, HYPOAESTHESIA (felt their legs were numb), ASTHENIA (weakness), FALL (fell to floor because of numbness), PYREXIA (had fever and chills), FATIGUE (extreme fatigue) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2020, SARS-CoV-2 test: (Positive) tested positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Nausea, Vomiting
Clinical narrative: Persisting diarrhea; nausea; tiredness; vomiting; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Persisting diarrhea), NAUSEA (nausea), FATIGUE (tiredness), VOMITING (vomiting) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced DIARRHOEA (Persisting diarrhea), NAUSEA (nausea), FATIGUE (tiredness), VOMITING (vomiting) and CHILLS (chills). At the time of the report, DIARRHOEA (Persisting diarrhea), NAUSEA (nausea), FATIGUE (tiredness), VOMITING (vomiting) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Fatigue
Clinical narrative: Feeling weak; Tired; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ASTHENIA (Feeling weak) and FATIGUE (Tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced DIARRHOEA (Diarrhea). On 01-Feb-2021, the patient experienced FATIGUE (Tired). On 02-Feb-2021, the patient experienced ASTHENIA (Feeling weak). On 01-Feb-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, ASTHENIA (Feeling weak) and FATIGUE (Tired) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Patient reported using Pepto tablets for Diahrrea
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fall, Fatigue, Hypoaesthesia, SARS-CoV-2 test
Clinical narrative: felt their legs were numb, for 15 seconds could not stand up, move legs; fell to floor because of numbness; weakness; extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (felt their legs were numb, for 15 seconds could not stand up, move legs), FALL (fell to floor because of numbness), ASTHENIA (weakness) and FATIGUE (extreme fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 20-Dec-2020.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (felt their legs were numb, for 15 seconds could not stand up, move legs), FALL (fell to floor because of numbness), ASTHENIA (weakness) and FATIGUE (extreme fatigue). At the time of the report, HYPOAESTHESIA (felt their legs were numb, for 15 seconds could not stand up, move legs), FALL (fell to floor because of numbness), ASTHENIA (weakness) and FATIGUE (extreme fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2020, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Malaise
Clinical narrative: Hypertension; Generally did not feel well; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HYPERTENSION (Hypertension) and MALAISE (Generally did not feel well) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced HYPERTENSION (Hypertension) and MALAISE (Generally did not feel well). On 26-Jan-2021, HYPERTENSION (Hypertension) and MALAISE (Generally did not feel well) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular
Clinical narrative: Rash on the arm where she received the vaccination, it's a big red blotch; Rash on the arm where she received the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Rash on the arm where she received the vaccination, it's a big red blotch) and RASH (Rash on the arm where she received the vaccination) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced RASH MACULAR (Rash on the arm where she received the vaccination, it's a big red blotch) and RASH (Rash on the arm where she received the vaccination). At the time of the report, RASH MACULAR (Rash on the arm where she received the vaccination, it's a big red blotch) and RASH (Rash on the arm where she received the vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Feb-2021: source doc attached
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site discolouration, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: it started to get a little pink; warm; hard; below where she got the shot, it was all red; her arm got really itchy; sore arm for 2 days; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm for 2 days), VACCINATION SITE DISCOLOURATION (it started to get a little pink), VACCINATION SITE WARMTH (warm), VACCINATION SITE INDURATION (hard) and VACCINATION SITE PRURITUS (her arm got really itchy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm for 2 days). On 27-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (her arm got really itchy). On 28-Jan-2021, the patient experienced VACCINATION SITE DISCOLOURATION (it started to get a little pink), VACCINATION SITE WARMTH (warm), VACCINATION SITE INDURATION (hard) and VACCINATION SITE ERYTHEMA (below where she got the shot, it was all red). At the time of the report, PAIN IN EXTREMITY (sore arm for 2 days) had resolved and VACCINATION SITE DISCOLOURATION (it started to get a little pink), VACCINATION SITE WARMTH (warm), VACCINATION SITE INDURATION (hard), VACCINATION SITE PRURITUS (her arm got really itchy) and VACCINATION SITE ERYTHEMA (below where she got the shot, it was all red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. patient took antibiotic and used warm compress to treat her symptoms, and purchased diphenhydramine to treat itchiness.   This case was linked to US-MODERNATX, INC.-MOD-2021-017586 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-017586:Wife case
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: it started to get a little pink; warm; hard; below where she got the shot, it was all red; her arm got really itchy; sore arm for 2 days; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm for 2 days), VACCINATION SITE DISCOLOURATION (it started to get a little pink), VACCINATION SITE WARMTH (warm), VACCINATION SITE INDURATION (hard) and VACCINATION SITE PRURITUS (her arm got really itchy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm for 2 days). On 27-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (her arm got really itchy). On 28-Jan-2021, the patient experienced VACCINATION SITE DISCOLOURATION (it started to get a little pink), VACCINATION SITE WARMTH (warm), VACCINATION SITE INDURATION (hard) and VACCINATION SITE ERYTHEMA (below where she got the shot, it was all red). At the time of the report, PAIN IN EXTREMITY (sore arm for 2 days) had resolved and VACCINATION SITE DISCOLOURATION (it started to get a little pink), VACCINATION SITE WARMTH (warm), VACCINATION SITE INDURATION (hard), VACCINATION SITE PRURITUS (her arm got really itchy) and VACCINATION SITE ERYTHEMA (below where she got the shot, it was all red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. patient took antibiotic and used warm compress to treat her symptoms, and purchased diphenhydramine to treat itchiness.   This case was linked to US-MODERNATX, INC.-MOD-2021-017586 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-017586:Wife case
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Rhinorrhoea, Vaccination site pain, Vaccination site swelling
Clinical narrative: Runny nose; Soar throat; Cough; Arm extremely sore; Arm Swollen; A spontaneous report was received from a consumer concerning a 57-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm extremely sore, arm swollen, runny nose, soar throat, and cough.  The patient's medical history was not provided. No relevant concomitant medications were reported. No relevant lab data was provided by the reporter.  On 22 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly in the arm for prophylaxis of COVID-19 infection.  On 22 Jan 2021, the patient experienced the events arm extremely sore and arm swollen . On 24 Jan 2021, the patient experienced the events runny nose, soar throat and cough. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of events, arm extremely sore, arm swollen, runny nose, soar throat and cough was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site urticaria
Clinical narrative: Rash that looks like hives, size of a silver doller; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) and VACCINATION SITE URTICARIA (Rash that looks like hives, size of a silver doller) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 31-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Rash that looks like hives, size of a silver doller). At the time of the report, PAIN IN EXTREMITY (Arm soreness) and VACCINATION SITE URTICARIA (Rash that looks like hives, size of a silver doller) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Patient did not take anything to alleviate her symptoms
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Racing heartbeat which gets worse when eating food; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Racing heartbeat which gets worse when eating food) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced HEART RATE INCREASED (Racing heartbeat which gets worse when eating food). At the time of the report, HEART RATE INCREASED (Racing heartbeat which gets worse when eating food) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.   This case was linked to MOD-2021-018027 (Patient Link).   Reporter did not allow further contact